Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible

NCT00922181 is registered in ClinicalTrials.gov with University Hospital, Gasthuisberg as lead sponsor.

NCT NCT00922181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00922181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible
Lead sponsor
University Hospital, Gasthuisberg
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2008
Completion date
April 30, 2009
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasms